AACR-CRI Lloyd J. Old Award in Cancer Immunology, USA
American Association for Cancer Research awards are open to all cancer immunologists who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
The AACR-CRI Lloyd J. Old Award in Cancer Immunology was established to honor the memory of the late Lloyd J. Old and will recognize an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field.
The American Association for Cancer Research (AACR) is the world’s oldest and largest professional association related to cancer research. Based in Philadelphia, the AACR focuses on all aspects of cancer research, including basic, clinical, and translational research into the etiology, prevention, diagnosis, and treatment of cancer. Founded in 1907 by 11 physicians and scientists, the organization now has more than 34,000 members in over 90 countries.
The recipient of the award will receive an honorarium of $10,000, give a 50-minute lecture during the AACR Annual Meeting 2017 in Washington, DC (April 1-5, 2017), and will be provided support for the winner and a guest to attend the AACR Annual Meeting 2017.
- The award is open to all cancer immunologists who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
- Candidates will be considered on the basis of their highly significant and innovative research, the impact of these discoveries on the cancer field, and the stimulation of new directions in cancer immunology. All areas of cancer immunology will be considered for this award.
- Candidates must currently maintain an active research program, have a record of recent publications, and be able to present an exciting award lecture at the annual meeting.
- The award will be presented to an individual investigator.
- Institutions or organizations are not eligible for the award.
Candidates will be considered by an Award Selection Committee composed of members nominated by both the Cancer Research Institute and the AACR. After careful deliberation by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the award recipient will be made on the basis of the candidate’s scientific accomplishments without regard to race, gender, nationality, geographic location, or religious or political views.
Nominations may be made by any scientist, whether an AACR member on nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.
Nominations must be emailed to awards-at-aacr.org by 4 p.m. U.S. ET on Wednesday, August 3, 2016. Paper nominations cannot be accepted.
Nomination materials to be submitted are:
1) Nomination Letter. The letter must:
- be addressed to the Selection Committee, be written in English, and not exceed 1,000 words;
- specify the AACR award for which the candidate is being nominated;
- contain a concise description of the candidate’s highly significant and innovative research, and the stimulation of new directions in cancer immunology, with the publications supporting these accomplishments directly referenced within the letter;
- contain a concise description of the impact of these accomplishments in the cancer field; and
- be signed with a handwritten signature by the nominator(s).
2) Candidate’s CV. The candidate’s curriculum vitae in English, including a complete list of the candidate’s publications.
3) Summary Statement. A statement, no more than 50 words, summarizing the candidate’s research accomplishments for which he or she is being nominated.
Full nomination instructions and program guidelines are available through the link below.